Skip to content
Agree.net – Lifestyle
Author:
PRECISIONeffect, Inc. dba Precision AQ
First-in-Human Use of CereVasc® eShunt® System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes
March 4, 2026